As part of its contribution to the fight against COVID-19, Sharp Singapore has donated 80 units of its FP-J30 air purifiers with Plasmacluster™ Technology to four hospitals in Singapore caring for COVID-19 patients. These hospitals include Changi General Hospital, Ng Teng Fong General Hospital, Singapore General Hospital and more. These air purifiers are recommended for a coverage area of 23m2, around the size of a patient ward or staff lounge. SHARP air purifiers, with patented Plasmacluster™ Technology, have been providing clean and pure indoor air to users since its inception two decades ago. A joint study done by SHARP with Kitasako Institute in 2004 has confirmed that there was a dramatic reduction in bacteria and viruses in the presence of Plasmacluster™ Technology Ions . According to a joint research by SHARP Corporation and the Insitut Pasteur in Ho Chi Minh City, the Plasmacluster™ Technology can inhibit the infectiousness of the airborne avian influenza A (H7N9) virus by 99% in approximately 47 minutes .
The joint research is centred on the release of Plasmacluster™ Technology’s positively charged hydrogen (H+(H2O)m) and negatively charged oxygen ions (O2-(H2O)n) simultaneously into the air. These ions instantaneously bond on the surface of airborne substances such as viruses, becoming highly reactive OH radicals that break down the proteins on the surface of the viruses and inhibit the virus activity. This technology has the same inhibiting effects on other strains of influenza viruses
including A/H1N1 , H5N1, H7N9 , FCoV (which belongs to the coronavirus group), and harmful microbes including E.Coli, MRSA, and TB .
In 1973, Sharp codified the unchanging spirit of its founder in the Company’s business philosophy and business creed. The business philosophy, which states Sharp’s vision, includes statements such as “Contribute to the culture, benefits and welfare of the people throughout the world.” This forms the foundation of Corporate Social Responsibility (CSR) at Sharp today, aimed at achieving co-existence and mutual prosperity with society and stakeholders. As part of this CSR movement, Sharp hopes to support frontline healthcare workers, and play a role in the fight against COVID-19. Knowing that their air purifiers can contribute a pivotal role in ensuring good air quality in hospitals with COVID-19 patients, Sharp has specially set aside these units to cater for the donation. All four hospitals are currently caring for COVID-19 patients.
“At Sharp, we are committed to contribute meaningfully to society through our two key principals – Sincerity and Creativity. Our Plasmacluster™ Technology has been proven since 2004, to inactivate air borne coronavirus. With more than 80 million units of air purifiers sold World-wide to-date, we are very confident in our products and the benefits that they bring to our consumers.” Said Mr. Seiji Hayakawa, Managing Director at Sharp Singapore Electronics Corporation Pte Ltd. “We hope that our contribution will help patients rest with a peace of mind, and staff to feel better secured, knowing that the air is being constantly cleansed with the Plasmacluster™ Technology ions in the enclosed spaces that they spend most of their time in.”